Acquired Aplastic Anemia Therapies: Immunosuppressive Therapy Versus Alternative Donor Hematopoietic Cell Transplantation
Journal of Hematology · 2024-06 · 13 (3) · 61-70
DOI: 10.14740/jh1264 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Hematology, 2024-06. Verfasst von Baldeep Wirk. Beteiligte Einrichtung: Cellular Immunotherapies and Transplant Program, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23219, USA. Email…. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cellular Immunotherapies and Transplant Program, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23219, USA. Email: baldeep.wirk@vcuhealth.org.
Zitieren
APA
Wirk, B. (2024). Acquired Aplastic Anemia Therapies: Immunosuppressive Therapy Versus Alternative Donor Hematopoietic Cell Transplantation. Journal of Hematology, 13(3), 61-70. https://doi.org/10.14740/jh1264
Vancouver
Wirk B. Acquired Aplastic Anemia Therapies: Immunosuppressive Therapy Versus Alternative Donor Hematopoietic Cell Transplantation. Journal of Hematology. 2024;13(3):61-70. doi:10.14740/jh1264
BibTeX
@article{Wirk2024,
author = {Wirk, Baldeep},
title = {Acquired Aplastic Anemia Therapies: Immunosuppressive Therapy Versus Alternative Donor Hematopoietic Cell Transplantation},
journal = {Journal of Hematology},
year = {2024},
volume = {13},
number = {3},
pages = {61--70},
doi = {10.14740/jh1264}
}
EUVIMED